Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Australia’s Basis Point launches newsletter and website focused on Significant Investors

Tuesday, June 11, 2013

Beverly Chandler, Opalesque London: Australia’s consultancy for business and marketing intelligence on the financial and investment markets Basis Point has launched a new website and newsletter focused on the new Significant Investor Visa which has been launched in Australia.

Basis Point’s founder and managing director, David Chin, outlined the new visa in Opalesque’s Asia Pacific Intelligence in the February issue.

Insights from the SIV Newsletter’s inaugural issue include:

  • The SIV industry could generate $5bn in capital inflows in its first full financial year. This is equivalent to one sixth the superannuation industry’s net inflows, or nearly half of all Australian IPOs, in 2011/2012.
  • 171 SIV applications have been lodged over the last three months.
  • A straw poll of SIV industry leaders indicates a pipeline of 400 plus applications which supports Basis Point's initial estimates of 1000 visas per year (to equate to $5bn in fresh capital inflows into Australia).
  • Foreign investment in Australia… China was ranked the third largest foreign investor last financial year but represented nearly half of all investment approvals.
  • Foreign real estate i......................

    To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its